Literature DB >> 16052363

Impaired platelet [3H]paroxetine binding in female patients with borderline personality disorder.

N M K Ng Ying Kin1, Joel Paris, George Schwartz, Hallie Zweig-Frank, Howard Steiger, N P V Nair.   

Abstract

RATIONALE: There have been few studies of platelet paroxetine binding in borderline personality disorder (BPD).
OBJECTIVE: Our aim was to determine whether female BPD subjects show abnormalities in platelet paroxetine binding.
METHODS: Twenty-one female BPD subjects and 16 age- and gender-matched normal control subjects were assessed using the following: (1) Diagnostic Interview for Borderlines, Revised, (2) Diagnostic Assessment for Personality Pathology: Brief Questionnaire, and (3) Barratt Impulsivity Scale. Platelets were collected and assayed for platelet paroxetine binding.
RESULTS: Bmax was lower in the BPD group (p < 0.0001), but differences in Kd only reached a trend level. There were no associations with trait dimensions independent of diagnosis.
CONCLUSIONS: Reduced platelet paroxetine binding in female BPD patients may reflect presynaptic serotonin dysfunction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16052363     DOI: 10.1007/s00213-005-0097-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  33 in total

1.  Self-ratings of anger and hostility in borderline personality disorder.

Authors:  D L Gardner; E Leibenluft; K M O'Leary; R W Cowdry
Journal:  J Nerv Ment Dis       Date:  1991-03       Impact factor: 2.254

2.  Implications of impulsive and affective symptoms for serotonin function in bulimia nervosa.

Authors:  H Steiger; S N Young; N M Kin; N Koerner; M Israel; P Lageix; J Paris
Journal:  Psychol Med       Date:  2001-01       Impact factor: 7.723

3.  Serotonergic responsivity and behavioral dimensions in antisocial personality disorder with substance abuse.

Authors:  H B Moss; J K Yao; G L Panzak
Journal:  Biol Psychiatry       Date:  1990-08-15       Impact factor: 13.382

4.  Childhood abuse and platelet tritiated-paroxetine binding in bulimia nervosa: implications of borderline personality disorder.

Authors:  H Steiger; S Léonard; N Y Kin; C Ladouceur; D Ramdoyal; S N Young
Journal:  J Clin Psychiatry       Date:  2000-06       Impact factor: 4.384

5.  Altered [3H]imipramine and 5-HT2 but not [3H]paroxetine binding sites in platelets from depressed patients.

Authors:  P Rosel; B Arranz; J Vallejo; P Alvarez; J M Menchon; T Palencia; M A Navarro
Journal:  J Affect Disord       Date:  1999 Jan-Mar       Impact factor: 4.839

6.  Serotonergic blunting to meta-chlorophenylpiperazine (m-CPP) highly correlates with sustained childhood abuse in impulsive and autoaggressive female borderline patients.

Authors:  T Rinne; H G Westenberg; J A den Boer; W van den Brink
Journal:  Biol Psychiatry       Date:  2000-03-15       Impact factor: 13.382

7.  Implications of compulsive and impulsive traits for serotonin status in women with bulimia nervosa.

Authors:  Howard Steiger; Mimi Israël; Lise Gauvin; N M K Ng Ying Kin; Simon N Young
Journal:  Psychiatry Res       Date:  2003-10-15       Impact factor: 3.222

8.  Neurobiological correlates of diagnosis and underlying traits in patients with borderline personality disorder compared with normal controls.

Authors:  Joel Paris; Hallie Zweig-Frank; N M K Ng Ying Kin; George Schwartz; Howard Steiger; N P V Nair
Journal:  Psychiatry Res       Date:  2004-01-01       Impact factor: 3.222

Review 9.  Central serotonin and impulsive aggression.

Authors:  E F Coccaro
Journal:  Br J Psychiatry Suppl       Date:  1989-12

10.  Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet.

Authors:  E F Coccaro; R J Kavoussi; Y I Sheline; J D Lish; J G Csernansky
Journal:  Arch Gen Psychiatry       Date:  1996-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.